Systemic Lupus Erythematosus Treatment Market Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028
Systemic Lupus Erythematosus Treatment Market
SLE is a chronic, autoimmune disorder that affects multiple organ systems, including the heart, kidneys, skin, joints, blood, lungs, and, in the most severe cases, the brain. The human immune system becomes hyperactive in this disease and attacks the body's normal, healthy tissues. This disease primarily affects women of Asian, Afro-Caribbean, and Hispanic descent. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, this disease is most prevalent in African-American and Asian populations.
Systemic Lupus
Erythematosus Treatment Market Segment Analysis
The immunosuppressive drugs segment leads the global
systemic lupus erythematosus treatment market in terms of drugs. This
is due to major pharmaceutical companies focusing on the release of new
immunosuppressive drugs.
Furthermore, immunosuppressive drugs for the treatment of
systemic lupus erythematosus are inexpensive, easily accessible, and highly
effective.
During the forecast period, the intravenous segment is
expected to be very appealing. Due to its rapid onset of action and low drug
degradation, major market players are focusing on launching new products in the
injection form, which is expected to propel the intravenous segment in the
global systemic lupus erythematosus treatment market.
Retail pharmacies are a popular distribution channel. The
expansion of retail pharmacy stores around the world, the availability of new
products in retail stores, and the availability of most drugs, such as NSAIDS,
antimalarial drugs, and corticosteroids as OTC drugs, are expected to drive the
growth of the retail pharmacies segment in the global systemic lupus
erythematosus treatment market.
Comments
Post a Comment